drugset / Trial / NCT07033481
Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia
RandomizedSequentialQuadruple-blindTreatment
Summary
The goal of this exploratory study is to evaluate the effect of neflamapimod in participants with nonfluent variant primary progressive aphasia (nfvPPA). We aim to evaluate the safety, pharmacokinetics and clinical effects of neflamapimod of participants with nfvPPA.
Timeline
- Start
- 2025-10-02
- Primary completion
- 2026-09
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neflamapimod | Small molecule | — | — |